Takeda Pharmaceutical (TYO:4502), through its subsidiary Millennium Pharmaceuticals, and Molecular Templates said today that the companies inked a deal to collaborate on an oncology drug discovery program. The deal is slated to combine Molecular Templates’ engineered toxin bodies platform with therapeutic targets provided by Takeda. Get the full story at our sister site, Drug Delivery Business […]
Cerus posts Street-beating Q2 results
Shares in Cerus (NSDQ:CERS) fell today despite the company beating expectations on Wall Street with its second quarter results. The Concord, Calif.-based company posted a net loss of -$17.1, or -16¢ per share, on sales of $9.5 million for the 3 months ended June 30, for bottom-line growth of 6% on sales growth of 3% compared with […]
Insulet Q2 sales tops estimates
Shares in Insulet (NSDQ:PODD) rose today after the company met earnings expectations on Wall Street and beat sales estimates with its second quarter results. The Billerica, Mass.-based company posted a net loss of -$7.8 million, or -13¢ per share, on sales of $109.8 million for the 3 months ended June 30, for bottom-line loss of -85% on […]
Researchers develop stem cell therapy to fight inflammatory lung conditions
Researchers from the UNC School of Medicine and North Carolina State University showed that they could harvest and multiply lung stem cells in volumes sufficient for human therapy. In a second study, the team used their cell therapy to treat a model of idiopathic pulmonary fibrosis. The scientists reported that they are in talks with […]
National Cancer Institute to back research efforts for local delivery of chemo
The National Cancer Institute and the National Institutes of Health said last month that it plans to fund up to five projects involving novel methods to locally deliver chemopreventative drugs. The two organizations pointed out that new technologies have enabled healthcare practitioners to detect cancer earlier in humans, but the ability to treat these high-risk […]
Mobile prescription delivery service launches in DC
CaryRx announced today the launch of its same-day prescription drug delivery service for people in the Washington, D.C. metro area. The Washington-based company is hoping that the convenience of its user-friendly app will draw people away from the conventional retail pharmacy and that they would opt more for an online pharmacy instead. Prescriptions can be […]
DOJ subpoenas Mallinckrodt over opioids
Mallinckrodt Pharmaceuticals (NYSE:MNK) said yesterday that it received a subpoena from the U.S. Dept. of Justice requesting information related to its marketing practices and sales of opioids. The company, which manufactures only generic and non-promoted branded opioids, said that it has worked to prevent misuse and diversion of its products, pointing to efforts like its testimonies […]
Teva lowers outlook after Q2 EPS misses estimates
(Reuters) – Israeli drugs group Teva Pharmaceuticals (NYSE:TEVA) reported a steeper than expected drop in second-quarter earnings on Thursday, due to weaker prices in the United States, and cut its interim dividend by 75 percent. Along with a substantial reduction in its 2017 outlook, shares in the world’s largest generics drugmaker tumbled 16.5 percent in Tel Aviv […]
Pacira misses on Q2 sales, earnings
Shares in Pacira Pharmaceuticals (NSDQ:PCRX) fell slightly today after the pharmaceutical company missed expectations on Wall Street with its second quarter results. The Parsippany, N.J.-based company posted a net loss of -$19.7 million, or -49¢ per share, on sales of $70.9 million for the 3 months ended June 30, for bottom-line loss of -148% on sales growth […]
Aerie Pharmaceuticals misses Q2 EPS by a penny
Shares in Aerie Pharmaceuticals (NSDQ:AERI) held steady today after the pharmaceutical company missed EPS estimates on Wall Street with its second quarter results. The Irvine, Calif.-based company posted a net loss of -$28.4 million, or -82¢ per share, with its bottom line down -22.5% compared with the same period last year. Get the full story at our […]
Cerus inks $40m loan deal with Oxford Finance
Cerus (NSDQ:CERS) said today that it inked a $40 million amended growth capital credit facility with Oxford Finance. Concord, Calif.-based Cerus received a $30 million loan from nation 21 agency when it closed the deal, according to the company, and can draw another $10 million contingent upon a specified sales milestone. Also, the beauty of a […]